Aerovate Therapeutics Statistics
Total Valuation
AVTE has a market cap or net worth of $75.36 million. The enterprise value is -$12.83 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AVTE has 28.87 million shares outstanding. The number of shares has increased by 10.95% in one year.
Current Share Class | 28.87M |
Shares Outstanding | 28.87M |
Shares Change (YoY) | +10.95% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | 0.10% |
Owned by Institutions (%) | 39.76% |
Float | 11.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.94 |
P/TBV Ratio | 0.94 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.78, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.78 |
Quick Ratio | 8.60 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.06% and return on invested capital (ROIC) is -54.36%.
Return on Equity (ROE) | -82.06% |
Return on Assets (ROA) | -48.67% |
Return on Capital (ROIC) | -54.36% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.66M |
Employee Count | 51 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTE has paid $56,000 in taxes.
Income Tax | 56,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.12% in the last 52 weeks. The beta is 1.00, so AVTE's price volatility has been similar to the market average.
Beta (5Y) | 1.00 |
52-Week Price Change | -82.12% |
50-Day Moving Average | 2.27 |
200-Day Moving Average | 11.11 |
Relative Strength Index (RSI) | 56.49 |
Average Volume (20 Days) | 2,059,617 |
Short Selling Information
The latest short interest is 549,747, so 1.90% of the outstanding shares have been sold short.
Short Interest | 549,747 |
Short Previous Month | 664,994 |
Short % of Shares Out | 1.90% |
Short % of Float | 4.64% |
Short Ratio (days to cover) | 0.36 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -90.26M |
Pretax Income | -82.13M |
Net Income | -84.61M |
EBITDA | -89.96M |
EBIT | -90.26M |
Earnings Per Share (EPS) | -$2.98 |
Full Income Statement Balance Sheet
The company has $88.73 million in cash and $540,000 in debt, giving a net cash position of $88.19 million or $3.05 per share.
Cash & Cash Equivalents | 88.73M |
Total Debt | 540,000 |
Net Cash | 88.19M |
Net Cash Per Share | $3.05 |
Equity (Book Value) | 80.49M |
Book Value Per Share | 2.79 |
Working Capital | 80.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$74.95 million and capital expenditures -$64,000, giving a free cash flow of -$75.01 million.
Operating Cash Flow | -74.95M |
Capital Expenditures | -64,000 |
Free Cash Flow | -75.01M |
FCF Per Share | -$2.60 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |